Brinker Capital Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,787
Closed -$676K 1736
2024
Q1
$676K Sell
9,787
-232
-2% -$14.7K 0.01% 1153
2023
Q4
$707K Sell
10,019
-1,000
-9% -$65.5K 0.01% 1083
2023
Q3
$752K Sell
11,019
-57,102
-84% -$4.84M 0.01% 1051
2023
Q2
$6.4M Sell
68,121
-367
-0.5% -$28.6K 0.07% 272
2023
Q1
$4.64M Buy
68,488
+21
+0% +$1.35K 0.06% 295
2022
Q4
$3.39M Buy
68,467
+1,198
+2% +$49K 0.07% 289
2022
Q3
$2.19M Buy
67,269
+152
+0.2% +$6.27K 0.05% 424
2022
Q2
$2.64M Sell
67,117
-25
-0% -$1.34K 0.05% 372
2022
Q1
$4.7M Sell
67,142
-1,653
-2% -$121K 0.07% 259
2021
Q4
$5.35M Buy
68,795
+48,376
+237% +$4.27M 0.08% 254
2021
Q3
$2.54M Hold
20,419
0.04% 473
2021
Q2
$2.54M Buy
20,419
+624
+3% +$74.5K 0.03% 529
2021
Q1
$2.61M Sell
19,795
-24,493
-55% -$3.35M 0.04% 432
2020
Q4
$5.87M Buy
44,288
+22,114
+100% +$2.67M 0.09% 261
2020
Q3
$2.26M Buy
+22,174
New +$1.91M 0.04% 430
2019
Q3
Sell
-178
Closed -$21K 811
2019
Q2
$21K Buy
+178
New +$17.9K ﹤0.01% 690

Other funds holding EXAS

Brinker Capital Investments's EXAS Position: Q2 2024 in Review

Brinker Capital Investments sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 9,787 shares — an estimated $676K sold.

Brinker Capital Investments first reported a position in EXAS in Q2 2019 and held it in 16 quarters. The position peaked at $6.4M in Q2 2023. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Brinker Capital Investments reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Brinker Capital Investments sold 9,787 Exact Sciences shares in Q2 2024, an estimated $676K.
  • Brinker Capital Investments first reported a position in Exact Sciences in Q2 2019 and held it in 16 quarters.
  • Brinker Capital Investments's Exact Sciences position peaked at $6.4M in Q2 2023.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Brinker Capital Investments's 13F filing for Q2 2024, filed 31 Jul 2025.